相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Osilodrostat in Cushing's disease: The risk of delayed adrenal insufficiency should be carefully monitored
Frederic Castinetti et al.
CLINICAL ENDOCRINOLOGY (2023)
Mental Health in Patients With Adrenal Incidentalomas: Is There a Relation With Different Degrees of Cortisol Secretion?
Valentina Morelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment
Sara G. Creemers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome
Eliza B. Geer et al.
PITUITARY (2021)
Hidden hypercortisolism: a too frequently neglected clinical condition
L. Giovanelli et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Cardiovascular complications of mild autonomous cortisol secretion
Carmen Aresta et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Risk of Bone Fractures after the Diagnosis of Adrenal Adenomas: A Population-based Cohort Study
Dingfeng Li et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Osilodrostat for the treatment of Cushing's disease
Syeda Rasool et al.
EXPERT OPINION ON PHARMACOTHERAPY (2021)
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study
Rosario Pivonello et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Association Between Mortality and Levels of Autonomous Cortisol Secretion by Adrenal Incidentalomas A Cohort Study
Albin Kjellbom et al.
ANNALS OF INTERNAL MEDICINE (2021)
When to Suspect Hidden Hypercortisolism in Type 2 Diabetes: A Meta-Analysis
Carmen Aresta et al.
ENDOCRINE PRACTICE (2021)
An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing's Syndrome and Autonomous Cortisol Secretion
Satoko Oda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Grand Challenge in Adrenal Endocrinology: Is the Legacy of the Past a Challenge for the Future of Precision Medicine?
Iacopo Chiodini et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
Rosario Pivonello et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Adrenally Directed Medical Therapies for Cushing Syndrome
Nicholas A. Tritos
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback
Yasutaka Tsujimoto et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Osilodrostat: A Novel Steroidogenesis Inhibitor to Treat Cushing's Disease
John A. Dougherty et al.
ANNALS OF PHARMACOTHERAPY (2021)
Cushing's syndrome: Treatment and new therapeutic approaches
Amandine Ferriere et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Adrenal Incidentaloma
Mark Sherlock et al.
ENDOCRINE REVIEWS (2020)
β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids
Federico Gatto et al.
JOURNAL OF ENDOCRINOLOGY (2020)
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
Irina Bancos et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Rosario Pivonello et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Advances in the Medical Treatment of Cushing Disease
Nicholas A. Tritos et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2020)
Approach to patients with bilateral adrenal incidentalomas
Dimitra A. Vassiliadi et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2020)
Evaluation and Treatment of Patients With Hypercortisolism A Review
Barbra S. Miller et al.
JAMA SURGERY (2020)
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
Rosario Pivonello et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Advances in the medical treatment of Cushing's syndrome
Richard A. Feelders et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY
Regina Belokovskay et al.
ENDOCRINE PRACTICE (2019)
Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)
Pejman Cohan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women
Iacopo Chiodini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess A Systematic Review and Meta-analysis
Yasir S. Elhassan et al.
ANNALS OF INTERNAL MEDICINE (2019)
Modern Management of Mild Autonomous Cortisol Secretion
Danae A. Delivanis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Toward a Diagnostic Score in Cushing's Syndrome
Leah T. Braun et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells
Federico Gatto et al.
PITUITARY (2019)
The medical treatment with pasireotide in Cushing's disease: an Italian multicentre experience based on real-world evidence
Rosario Pivonello et al.
ENDOCRINE (2019)
Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities
Iacopo Chiodini et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Recent Advances on Subclinical Hypercortisolism
Guido Zavatta et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis
Leonie H. A. Broersen et al.
PITUITARY (2018)
A dual role for glucocorticoid-induced leucine zipper in glucocorticoid function: tumor growth promotion or suppression?
Emira Ayroldi et al.
CELL DEATH & DISEASE (2018)
Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review
Hideyuki Iwayama et al.
BMC ENDOCRINE DISORDERS (2018)
Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults
Roberto Cesareo et al.
NUTRIENTS (2018)
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
Andre Lacroix et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Effect of cabergoline monotherapy in Cushing's disease: an individual participant data meta-analysis
R. Palui et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Dopamine Agonists for Pituitary Adenomas
Odelia Cooper et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Preoperative treatment with metyrapone in patients with Cushing's syndrome due to adrenal adenoma: a pilot prospective study
Soraya Puglisi et al.
ENDOCRINE CONNECTIONS (2018)
Metyrapone treatment in Cushing's syndrome: a real-life study
Filippo Ceccato et al.
ENDOCRINE (2018)
Cabergoline for Cushing's disease: a large retrospective multicenter study
A. Ferriere et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks
Valentina Morelli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion
Miguel Debono et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Significance of dopamine D1 receptor signalling for steroidogenic differentiation of human induced pluripotent stem cells
Koji Matsuo et al.
SCIENTIFIC REPORTS (2017)
Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center
Jekaterina Patrova et al.
ENDOCRINE (2017)
Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?
Cristina Eller-Vainicher et al.
ENDOCRINE (2017)
Six controversial issues on subclinical Cushing's syndrome
Iacopo Chiodini et al.
ENDOCRINE (2017)
No Untoward Effect of Long-Term Ketoconazole Administration on Electrocardiographic QT Interval in Patients with Cushing's Disease
Martina De Martin et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism
Antonio Stefano Salcuni et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Design, synthesis, and evaluation of (2S, 4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome
Benjamin E. Blass et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Endogenous subclinical hypercortisolism and bone: a clinical review
I. Chiodini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis
Irina Bancos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies
Maria Fleseriu et al.
PITUITARY (2016)
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience
N. M. Albiger et al.
CLINICAL ENDOCRINOLOGY (2015)
The Treatment of Cushing's Disease
Rosario Pivonello et al.
ENDOCRINE REVIEWS (2015)
Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas
I. Perogamvros et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Cushing's syndrome: update on signs, symptoms and biochemical screening
Lynnette K. Nieman
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Steroidogenesis enzyme inhibitors in Cushing's syndrome
Eleni Daniel et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
Eleni Daniel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension
Henry G. Fein et al.
BMC ENDOCRINE DISORDERS (2015)
Differences Between Bilateral Adrenal Incidentalomas and Unilateral Lesions
Jesse D. Pasternak et al.
JAMA SURGERY (2015)
Ketoconazole in Cushing's Disease: Is It Worth a Try?
Frederic Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas
Miguel Debono et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Dual Effects of Ketoconazole cis-Enantiomers on CYP3A4 in Human Hepatocytes and HepG2 Cells
Aneta Novotna et al.
PLOS ONE (2014)
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study
Guido Di Dalmazi et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia
Sophie Comte-Perret et al.
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2014)
Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics
V. Morelli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism
S. Palmieri et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
Robert R. Henry et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study
Miguel Debono et al.
PLOS ONE (2013)
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
Annamaria Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
AME Position Statement on adrenal incidentaloma
M. Terzolo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Diagnosis and Treatment of Subclinical Hypercortisolism
Iacopo Chiodini
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects
V. Morelli et al.
CLINICAL ENDOCRINOLOGY (2010)
The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
Julio Rosenstock et al.
DIABETES CARE (2010)
Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma
Cristina Eller-Vainicher et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Ketoconazole enantiomer for the treatment of diabetes mellitus
Richard Arakaki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas
Toru Tateno et al.
ENDOCRINE JOURNAL (2009)
Merits and pitfalls of mifepristone in Cushing's syndrome
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Safety profile and metabolic effects of 14 days of treatment with DIO-902: Results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus
Sherwyn L. Schwartz et al.
CLINICAL THERAPEUTICS (2008)
Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine Cushing's disease
C. de Bruin et al.
ENDOCRINOLOGY (2008)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
The diagnosis of Cushing's syndrome: An endocrine society clinical practice guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Cortisol secretion in patients with type 2 diabetes - Relationship with chronic complications
Iacopo Chiodini et al.
DIABETES CARE (2007)
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
LJ Hofland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Dopamine receptor expression and function in corticotroph pituitary tumors
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
C Bruns et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Dopamine D2 receptor gene expression in human adenohypophysial adenomas
L Stefaneanu et al.
ENDOCRINE (2001)
分享论文
